Raymond James & Associates’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,154	Closed	-$279K	–	3996
2020 Q4	$279K	Buy	6,154 +492	+9%	+$18.7K	﹤0.01%	3160
2020 Q3	$200K	Sell	5,662 -65	-1%	-$2.35K	﹤0.01%	3212
2020 Q2	$216K	Buy	+5,727	New	+$189K	﹤0.01%	3079
2020 Q1	–	Sell	-5,905	Closed	-$306K	–	3501
2019 Q4	$306K	Sell	5,905 -58	-1%	-$3.37K	﹤0.01%	3072
2019 Q3	$327K	Sell	5,963 -1,380	-19%	-$70.9K	﹤0.01%	2956
2019 Q2	$298K	Sell	7,343 -378	-5%	-$13.8K	﹤0.01%	3017
2019 Q1	$233K	Buy	7,721 +1,600	+26%	+$54.8K	﹤0.01%	3134
2018 Q4	$206K	Sell	6,121 -1,259	-17%	-$45.4K	﹤0.01%	3108
2018 Q3	$311K	Sell	7,380 -278	-4%	-$11K	﹤0.01%	3003
2018 Q2	$245K	Buy	7,658 +3,498	+84%	+$144K	﹤0.01%	3138
2018 Q1	$207K	Buy	+4,160	New	+$235K	﹤0.01%	3116
2013 Q4	–	Sell	-13,787	Closed	-$329K	–	1962
2013 Q3	$329K	Buy	13,787 +601	+5%	+$13.5K	﹤0.01%	1750
2013 Q2	$224K	Buy	+13,186	New	+$190K	﹤0.01%	1813